IRIS Accounts Production v25.2.0.378 06178552 Board of Directors 1.10.23 31.12.24 31.12.24 30.9.25 false true true false false false true false Auditors Opinion iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh061785522023-09-30061785522024-12-31061785522023-10-012024-12-31061785522022-09-30061785522022-10-012023-09-30061785522023-09-3006178552ns15:EnglandWales2023-10-012024-12-3106178552ns14:PoundSterling2023-10-012024-12-3106178552ns10:Director12023-10-012024-12-3106178552ns10:PrivateLimitedCompanyLtd2023-10-012024-12-3106178552ns10:SmallEntities2023-10-012024-12-3106178552ns10:Audited2023-10-012024-12-3106178552ns10:SmallCompaniesRegimeForDirectorsReport2023-10-012024-12-3106178552ns10:SmallCompaniesRegimeForAccounts2023-10-012024-12-3106178552ns10:FullAccounts2023-10-012024-12-310617855212023-10-012024-12-3106178552ns10:Director22023-10-012024-12-3106178552ns10:Director32023-10-012024-12-3106178552ns10:Director42023-10-012024-12-3106178552ns10:Director52023-10-012024-12-3106178552ns10:RegisteredOffice2023-10-012024-12-3106178552ns5:CurrentFinancialInstruments2024-12-3106178552ns5:CurrentFinancialInstruments2023-09-3006178552ns5:ShareCapital2024-12-3106178552ns5:ShareCapital2023-09-3006178552ns5:RetainedEarningsAccumulatedLosses2024-12-3106178552ns5:RetainedEarningsAccumulatedLosses2023-09-3006178552ns5:ComputerSoftware2023-10-012024-12-3106178552ns5:IntangibleAssetsOtherThanGoodwill2023-09-3006178552ns5:IntangibleAssetsOtherThanGoodwill2023-10-012024-12-3106178552ns5:IntangibleAssetsOtherThanGoodwill2024-12-3106178552ns5:IntangibleAssetsOtherThanGoodwill2023-09-3006178552ns5:PlantMachinery2023-09-3006178552ns5:PlantMachinery2023-10-012024-12-3106178552ns5:PlantMachinery2024-12-3106178552ns5:PlantMachinery2023-09-3006178552ns5:WithinOneYearns5:CurrentFinancialInstruments2024-12-3106178552ns5:WithinOneYearns5:CurrentFinancialInstruments2023-09-30
REGISTERED NUMBER: 06178552 (England and Wales)






















Report of the Directors and

Financial Statements

for the period

1 October 2023 to 31 December 2024

for

20/30 Labs Limited

20/30 Labs Limited (Registered number: 06178552)






Contents of the Financial Statements
for the period 1 October 2023 to 31 December 2024




Page

Company Information 1

Report of the Directors 2

Balance Sheet 4

Notes to the Financial Statements 5


20/30 Labs Limited

Company Information
for the period 1 October 2023 to 31 December 2024







DIRECTORS: M Lindsay - Smart
J J Bruins
S Britt Denise
MS Smart
V J Bremmer



REGISTERED OFFICE: 1-2 Charterhouse Mews
London
EC1M 6BB



REGISTERED NUMBER: 06178552 (England and Wales)



AUDITORS: Anstey Bond LLP
Statutory Auditors &
Chartered Accountants
1-2 Charterhouse Mews
London
EC1M 6BB



BANKERS: HSBC
14-18 Finsbury Square
EC2A 1BR
London

20/30 Labs Limited (Registered number: 06178552)

Report of the Directors
for the period 1 October 2023 to 31 December 2024

The directors present their report with the financial statements of the company for the period 1 October 2023 to 31 December 2024.

DIRECTORS
The directors shown below have held office during the whole of the period from 1 October 2023 to the date of this report.

M Lindsay - Smart
MS Smart

Other changes in directors holding office are as follows:

J J Bruins - appointed 30 August 2024
S Britt Denise - appointed 30 August 2024

V J Bremmer was appointed as a director after 31 December 2024 but prior to the date of this report.

STATEMENT OF DIRECTORS' RESPONSIBILITIES
The directors are responsible for preparing the Report of the Directors and the financial statements in accordance with applicable law and regulations.

Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law), including Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'. Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and of the profit or loss of the company for that period. In preparing these financial statements, the directors are required to:

-select suitable accounting policies and then apply them consistently;
-make judgements and accounting estimates that are reasonable and prudent;
-prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.

The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the company's transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

STATEMENT AS TO DISCLOSURE OF INFORMATION TO AUDITORS
So far as the directors are aware, there is no relevant audit information (as defined by Section 418 of the Companies Act 2006) of which the company's auditors are unaware, and each director has taken all the steps that he or she ought to have taken as a director in order to make himself or herself aware of any relevant audit information and to establish that the company's auditors are aware of that information.

AUDITORS
The auditors, Anstey Bond LLP, will be proposed for re-appointment at the forthcoming Annual General Meeting.


20/30 Labs Limited (Registered number: 06178552)

Report of the Directors
for the period 1 October 2023 to 31 December 2024

This report has been prepared in accordance with the provisions of Part 15 of the Companies Act 2006 relating to small companies.

ON BEHALF OF THE BOARD:





M Lindsay - Smart - Director


30 September 2025

20/30 Labs Limited (Registered number: 06178552)

Balance Sheet
31 December 2024

2024 2023
Notes £    £   
FIXED ASSETS
Intangible assets 5 3,252 5,469
Tangible assets 6 378,715 511,171
381,967 516,640

CURRENT ASSETS
Stocks 137,698 339,276
Debtors 7 1,120,271 1,202,688
Cash and cash equivalents 721,415 805,216
1,979,384 2,347,180
CREDITORS
Amounts falling due within one year 8 (752,616 ) (1,301,758 )
NET CURRENT ASSETS 1,226,768 1,045,422
TOTAL ASSETS LESS CURRENT
LIABILITIES

1,608,735

1,562,062

PROVISIONS FOR LIABILITIES (49,579 ) (124,154 )
NET ASSETS 1,559,156 1,437,908

CAPITAL AND RESERVES
Called up share capital 555 555
Retained earnings 1,558,601 1,437,353
1,559,156 1,437,908

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 30 September 2025 and were signed on its behalf by:





M Lindsay - Smart - Director


20/30 Labs Limited (Registered number: 06178552)

Notes to the Financial Statements
for the period 1 October 2023 to 31 December 2024

1. STATUTORY INFORMATION

20/30 Labs Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

The financial statements are prepared in sterling, which is the functional currency of the company.

Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

Turnover
Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business, and is shown net of VAT and other sales related taxes. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Computer software is being amortised evenly over its estimated useful life of nil years.

Tangible fixed assets
Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Leasehold improvements 25% reducing balance
Plant and equipment 25% reducing balance
Fixtures and fittings 25% reducing balance
Motor vehicles 25% reducing balance

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

At each reporting period end date, the company reviews the carrying amounts of its tangible and intangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any).

An impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the impairment loss is treated as a revaluation decrease.

20/30 Labs Limited (Registered number: 06178552)

Notes to the Financial Statements - continued
for the period 1 October 2023 to 31 December 2024

2. ACCOUNTING POLICIES - continued

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the stocks to their present location and condition.

At each reporting date, an assessment is made for impairment. Any excess of the carrying amount of stocks over its estimated selling price less costs to complete and sell is recognised as an impairment loss in profit or loss. Reversals of impairment losses are also recognised in profit or loss.

Financial instruments

The company has elected to apply the provisions of Section 11 'Basic Financial Instruments' and Section 12 'Other Financial Instruments Issues' of FRS 102 to all of its financial instruments.

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets
Basic financial assets, which include debtors and cash and bank balances, are initially measured at
transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Impairment of financial assets
Financial assets, other than those held at fair value, which are dealt with through profit and loss, are assessed for indicators of impairment at each reporting end date.

Derecognition of financial assets
Financial assets are derecognised only when the contractual rights to the cash flows from the asset expire or are settled, or when the company transfers the financial asset and substantially all the risks and rewards of ownership to another entity, or if some significant risks and rewards of ownership are retained but control of the asset has transferred to another party that is able to sell the asset in its entirety to an unrelated third party.

Classification of financial liabilities
Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the
assets of the company after deducting all of its liabilities.

Basic financial liabilities
Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.


20/30 Labs Limited (Registered number: 06178552)

Notes to the Financial Statements - continued
for the period 1 October 2023 to 31 December 2024

2. ACCOUNTING POLICIES - continued
Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.
Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

Derecognition of financial liabilities
Financial liabilities are derecognised when the company's contractual obligations expire or are discharged or cancelled.

Taxation
The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as
reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company's liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are
recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the profit and loss account, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.

Research and development
Research expenditure is written off against profits in the year in which it is incurred. Identifiable development expenditure is capitalised to the extent that the technical, commercial and financial feasibility can be demonstrated.

Foreign currencies
Assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the balance sheet date. Transactions in foreign currencies are translated into sterling at the rate of exchange ruling at the date of transaction. Exchange differences are taken into account in arriving at the operating result.

20/30 Labs Limited (Registered number: 06178552)

Notes to the Financial Statements - continued
for the period 1 October 2023 to 31 December 2024

2. ACCOUNTING POLICIES - continued

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Leases are classified as finance leases whenever the terms of the lease transfer substantially all the risks and rewards of ownership to the lessees. All other leases are classified as operating leases.

Assets held under finance leases are recognised as assets at the lower of the assets fair value at the date of inception and the present value of the minimum lease payments. The related liability is included in the balance sheet as a finance lease obligation. Lease payments are treated as consisting of capital and interest elements. The interest is charged to profit or loss so as to produce a constant periodic rate of interest on the remaining balance of the liability.

Rentals payable under operating leases, including any lease incentives received, are charged to profit or loss on a straight line basis over the term of the relevant lease except where another more systematic basis is more representative of the time pattern in which economic benefits from the leases asset are consumed.

Employee benefits
The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets. The cost of any unused holiday entitlement is recognised in the period in which the employee's services are received.

Termination benefits are recognised immediately as an expense when the company is demonstrably
committed to terminate the employment of an employee or to provide termination benefits.

Retirement benefits
Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the period was 45 (2023 - 45 ) .

4. AUDITORS' REMUNERATION
Period
1.10.23
to Year Ended
31.12.24 30.9.23
£    £   
Fees payable to the company's auditors for the audit of the company's
financial statements

10,000

-

20/30 Labs Limited (Registered number: 06178552)

Notes to the Financial Statements - continued
for the period 1 October 2023 to 31 December 2024

5. INTANGIBLE FIXED ASSETS
Other
intangible
assets
£   
COST
At 1 October 2023
and 31 December 2024 7,095
AMORTISATION
At 1 October 2023 1,626
Charge for period 2,217
At 31 December 2024 3,843
NET BOOK VALUE
At 31 December 2024 3,252
At 30 September 2023 5,469

6. TANGIBLE FIXED ASSETS
Plant and
machinery
etc
£   
COST
At 1 October 2023 1,406,237
Additions 19,595
Disposals (4,900 )
At 31 December 2024 1,420,932
DEPRECIATION
At 1 October 2023 895,066
Charge for period 149,218
Eliminated on disposal (2,067 )
At 31 December 2024 1,042,217
NET BOOK VALUE
At 31 December 2024 378,715
At 30 September 2023 511,171

7. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Trade debtors 485,484 770,098
Other debtors 634,787 432,590
1,120,271 1,202,688

20/30 Labs Limited (Registered number: 06178552)

Notes to the Financial Statements - continued
for the period 1 October 2023 to 31 December 2024

8. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Trade creditors 145,849 518,800
Amounts owed to group undertakings 432,437 -
Taxation and social security 49,785 104,411
Other creditors 124,545 678,547
752,616 1,301,758

9. DISCLOSURE UNDER SECTION 444(5B) OF THE COMPANIES ACT 2006

The Report of the Auditors was unqualified.

Michael Whyke FCA CF (Senior Statutory Auditor)
for and on behalf of Anstey Bond LLP

10. RELATED PARTY DISCLOSURES

At the balance sheet date the company owed £Nil (2023: £490,774) to key management personnel.

At the balance sheet date the company was owed £284,852 to (2023: £58,446 owed by) 20/30 Products Ltd, a company under common control.

As at the balance sheet date the balance due from Normec Environmental Testing Limited a related company amounted to £148,312 (2023: £NIL).

As at the balance sheet date the balance due from Normec Holding UK Limited a related company amounted to £400,000 (2023: £NIL).

There are no terms for the repayment of capital or payment of interest.

11. ULTIMATE CONTROLLING PARTY

Normec Environmental Testing Limited is the ultimate controlling party by virtue of the shareholdings.